AGRF achieves Olink® Certified Service Provider Status

“Proteomics is an incredibly valuable field with diverse applications. Large swathes of the research community will benefit greatly from the adoption of its technologies and methods. It is exciting that AGRF is expanding into proteomics with the Olink platform, which has demonstrated substantial utility in biomarker discovery and precision medicine research.”

Ben Cooper, AGRF Technical Officer, Olink

AGRF are proud to announce its recent recognition as an Olink® Certified Service Provider.  This certification marks a significant milestone in our commitment to advancing proteomic research and precision medicine in Australia.

As a certified provider of Olink services, AGRF joins a select group of laboratories globally recognised for their expertise and excellence in using Olink’s ground breaking proteomic technology and underscores our dedication to delivering the highest standards of quality and reliability in proteomic analysis.

What it means to be an Olink Certified Provider?

Achieving Olink certification involves rigorous training and stringent quality control measures to ensure our services meet Olink’s exacting standards.  This certification assures our clients that AGRF is equipped with the latest Olink® Explore platform, capable of high-throughput and precise measurement of over 5,400 proteins in a single plasma sample. This technology is revolutionising the field of proteomics by providing deep insights into protein biomarkers, including cytokines and chemokines, which are important for understanding disease mechanisms.

Clients partnering with AGRF will benefit from the enhanced capabilities that come with Olink’s certification. Our advanced proteomic service will enable researchers to accelerate their studies with greater accuracy and efficiency, facilitating discoveries in disease biology, drug development and personalised medicine.

AGRF’s local support ensures that Australian researchers have direct access to this state-of-the-art proteomic analysis platform, enabling them to integrate protein-level data with genomic and transcriptomic information.  This access fosters closer collaboration and innovation within the local research community, driving advancements in research and discovery.

We are excited to see the transformative impact of this technology will have on the scientific community and look forward to contributing to the next wave of advancement in precision medicine.

Contact us today if you would like to learn more about our Olink service: www.agrf.org.au/olink